Compound page for C00005 (NADPH): EzCatDB EzCatDB

Compound page for C00005: NADPH

Top page for Compound List

Formula: C21H30N7O17P3




Link to ChEBI
16474

Link to pubchem
5884

There are 75 entries for this compound.
  • S00522: 1.10.99.2 ; Ribosyldihydronicotinamide dehydrogenase {quinone} (Catalytic domain; 3.40.50.360)
  • S00553: 1.1.1.100 ; 3-oxoacyl-[acyl carrier protein] reductase (Catalytic domain; 3.40.50.720)
  • S00328: 1.1.1.100 ; 3-oxoacyl-[acyl-carrier-protein] reductase (Catalytic domain; 3.40.50.720)
  • D00545: 1.1.1.100 ; 3-oxoacyl-(Acyl-carrier protein) reductase (Catalytic domain; 3.40.50.720)
  • S00602: 1.1.1.10 ; L-xylulose reductase (Catalytic domain; 3.40.50.720)
  • D00601: 1.1.1.133 ; dTDP-4-dehydrorhamnose reductase (Catalytic domain; 3.40.50.720)
  • S00604: 1.1.1.138 ; NADP-dependent mannitol dehydrogenase (Catalytic domain; 3.40.50.720)
  • S00329: 1.1.1.153 ; Sepiapterin reductase (Catalytic domain; 3.40.50.720)
  • T00003: 1.1.1.158 ; UDP-N-acetylenolpyruvoylglucosamine reductase (Catalytic domain; 3.30.465.10, 3.90.78.10)
  • S00330: 1.1.1.159 ; 7-alpha-hydroxysteroid dehydrogenase (Catalytic domain; 3.40.50.720)
  • D00603: 1.1.1.169 ; 2-dehydropantoate 2-reductase (Catalytic domain; 1.10.1040.10, 3.40.50.720)
  • S00543: 1.1.1.184, 1.1.1.189, 1.1.1.197 ; Carbonyl reductase [NADPH] 1 (Catalytic domain; 3.40.50.720)
  • S00331: 1.1.1.184 ; Sniffer (Catalytic domain; 3.40.50.720)
  • S00552: 1.1.1.206 ; Tropinone reductase 1 (Catalytic domain; 3.40.50.720)
  • S00229: 1.1.1.213 ; 3-alpha-hydroxysteroid dehydrogenase (Catalytic domain; 3.20.20.100)
  • S00228: 1.1.1.21 ; Aldose reductase-related protein 2 (Catalytic domain; 3.20.20.100)
  • S00332: 1.1.1.236 ; Tropinone reductase 2 (Catalytic domain; 3.40.50.720)
  • S00336: 1.1.1.252 ; Tetrahydroxynaphthalene reductase (Catalytic domain; 3.40.50.720)
  • T00414: 1.1.1.25, 5.4.99.5 ; Fusion: chorismate mutase and shikimate 5-dehydrogenase (Catalytic domain; 3.40.192.10)
  • D00857: 1.1.1.25 ; Shikimate 5-dehydrogenase-like protein HI0607 (Catalytic domain; 3.40.50.720, 3.40.192.10)
  • D00845: 1.1.1.25 ; Shikimate dehydrogenase (Catalytic domain; 3.40.192.10)
  • D00604: 1.1.1.271 ; GDP-L-fucose synthetase (Catalytic domain; 3.40.50.720, 3.90.25.10)
  • D00605: 1.1.1.282 ; Quinate/shikimate dehydrogenase (Catalytic domain; 3.40.192.10)
  • S00227: 1.1.1.2 ; Alcohol dehydrogenase {NADP+} (Catalytic domain; 3.20.20.100)
  • D00002: 1.1.1.2 ; NADP-dependent alcohol dehydrogenase (Catalytic domain; 3.40.50.720, 3.90.180.10)
  • D00492: 1.1.1.2 ; NADP-dependent alcohol dehydrogenase (Catalytic domain; 3.40.50.720, 3.90.180.10)
  • M00180: 1.1.1.34 ; 3-hydroxy-3-methylglutaryl-coenzyme A reductase (Catalytic domain; 3.30.70.420, 3.90.770.10)
  • D00458: 1.1.1.38 ; NAD-dependent malic enzyme (Catalytic domain; 3.40.192.10)
  • D00003: 1.1.1.3 ; Homoserine dehydrogenase (Catalytic domain; 3.30.360.10)
  • S00416: 1.1.1.42 ; Isocitrate dehydrogenase {NADP} (Catalytic domain; 3.40.718.10)
  • T00002: 1.1.1.44 ; 6-phosphogluconate dehydrogenase (Catalytic domain; 1.10.1040.10, 3.40.50.720)
  • S00324: 1.1.1.47 ; Glucose 1-dehydrogenase (Catalytic domain; 3.40.50.720)
  • D00010: 1.1.1.49 ; Glucose-6-phosphate 1-dehydrogenase (Catalytic domain; 3.30.360.10)
  • S00610: 1.1.1.51 ; 3-beta-hydroxysteroid dehydrogenase (Catalytic domain; 3.40.50.720)
  • S00327: 1.1.1.62 ; Estradiol 17-beta-dehydrogenase 1 (Catalytic domain; 3.40.50.720)
  • M00171: 1.1.1.82 ; Malate dehydrogenase [NADP] (Catalytic domain; 3.90.110.10, 4.-.-.-)
  • D00012: 1.1.1.86 ; Ketol-acid reductoisomerase (Catalytic domain; 1.10.1040.10, 3.40.50.720)
  • M00151: 1.14.13.25 ; Methane monooxygenase component A alpha chain (Catalytic domain; 1.10.620.20)
  • D00064: 1.14.13.2 ; P-hydroxybenzoate hydroxylase (Catalytic domain; 3.30.9.10)
  • T00025: 1.14.13.7 ; Phenol 2-monooxygenase (Catalytic domain; 3.30.9.10, 3.50.50.60)
  • M00138: 1.14.13.7 ; Phenol hydroxylase P2 protein (Catalytic domain; )
  • D00071: 1.18.1.2 ; NADPH:adrenodoxin oxidoreductase (Catalytic domain; 3.40.50.720, 3.50.50.60)
  • D00017: 1.1.99.28 ; Glucose--fructose oxidoreductase (Catalytic domain; 3.30.360.10, 3.40.50.720)
  • D00023: 1.2.1.11 ; Aspartate-semialdehyde dehydrogenase (Catalytic domain; 3.30.360.10)
  • D00614: 1.2.1.41 ; Gamma-glutamyl phosphate reductase (Catalytic domain; 3.40.309.10)
  • D00475: 1.2.1.4 ; NADP-dependent fatty aldehyde dehydrogenase (Catalytic domain; 3.40.309.10, 3.40.605.10)
  • D00476: 1.2.1.59 ; Glyceraldehyde-3-phosphate dehydrogenase (Catalytic domain; 3.30.360.10)
  • D00020: 1.2.1.5 ; Aldehyde dehydrogenase (Catalytic domain; 3.40.309.10, 3.40.605.10)
  • D00022: 1.2.1.9 ; Glyceraldehyde-3-phosphate dehydrogenase (NADP+) (Catalytic domain; 3.40.309.10, 3.40.605.10)
  • S00335: 1.3.1.24, 1.5.1.30 ; Flavin reductase (Catalytic domain; 3.40.50.720)
  • D00027: 1.3.1.24 ; Biliverdin reductase A (Catalytic domain; 3.40.50.720)
  • D00028: 1.3.1.26 ; Dihydrodipicolinate reductase (Catalytic domain; 3.30.360.10, 3.40.50.720)
  • D00034: 1.4.1.16 ; Meso-diaminopimelate D-dehydrogenase (Catalytic domain; 3.30.360.10, 3.40.50.720)
  • T00011: 1.4.1.3 ; Glutamate dehydrogenase 1 (Catalytic domain; 3.40.192.10)
  • D00032: 1.4.1.3 ; Glutamate dehydrogenase (Catalytic domain; 3.40.192.10)
  • T00219: 1.5.1.10 ; Saccharopine dehydrogenase {NADP+ (Catalytic domain; 3.30.360.10)
  • S00238: 1.5.1.20 ; 5,10-methylenetetrahydrofolate reductase (Catalytic domain; 3.20.20.220)
  • S00388: 1.5.1.34, 1.-.-.- ; Oxygen-insensitive NAD(P)H nitroreductase (Catalytic domain; 3.40.109.10)
  • S00339: 1.5.1.34 ; Dihydropteridine reductase (Catalytic domain; 3.40.50.720)
  • S00067: 1.5.1.3 ; Dihydrofolate reductase type 2 (Catalytic domain; 2.30.30.60)
  • M00210: 1.5.1.5, 3.5.4.9, 6.3.4.3 ; C-1-tetrahydrofolate synthase (Catalytic domain; 3.40.50.720, 3.40.192.10)
  • M00162: 1.6.1.2 ; NAD(P) transhydrogenase (Catalytic domain; 3.40.50.1220)
  • M00161: 1.6.1.2 ; NAD(P) transhydrogenase subunit alpha part 1 (Catalytic domain; 3.40.50.720, 3.40.50.1220, 3.40.50.1770)
  • M00154: 1.6.2.4, 1.14.14.1 ; Bifunctional P-450/NADPH-P450 reductase (Catalytic domain; 1.10.630.10)
  • M00006: 1.6.2.4 ; NADPH--cytochrome P450 reductase (Catalytic domain; 2.40.30.10, 3.40.50.80)
  • S00343: 1.6.5.2 ; NAD(P)H dehydrogenase [quinone] 1 (Catalytic domain; 3.40.50.360)
  • D00048: 1.6.5.5 ; Quinone oxidoreductase (Catalytic domain; 3.40.50.720, 3.90.180.10)
  • S00219: 1.6.99.1 ; NADPH dehydrogenase 1 (Catalytic domain; 3.20.20.70)
  • S00385: 1.6.99.- ; Major NAD(P)H-flavin oxidoreductase (Catalytic domain; 3.40.109.10)
  • S00031: 1.7.1.14 ; Cytochrome P450 55A1 (Catalytic domain; 1.10.630.10)
  • T00242: 1.8.1.12 ; Trypanothione reductase (TR) (EC 1.8.1.12) (N(1),N (Catalytic domain; 3.30.390.30, 3.50.50.60)
  • M00164: 1.8.1.2 ; Sulfite reductase [NADPH] flavoprotein alpha-component (Catalytic domain; 3.30.413.10, 3.90.480.10)
  • T00213: 1.8.1.7 ; Glutathione reductase (Catalytic domain; 3.30.390.30, 3.50.50.60)
  • D00045: 1.8.1.9 ; Thioredoxin reductase 1 (Catalytic domain; 3.50.50.60)
  • S00387: 1.-.-.- ; Oxygen-insensitive NADPH nitroreductase (Catalytic domain; 3.40.109.10)
    • Copyright: Nozomi Nagano, JST & CBRC-AIST
    Funded by PRESTO/Japan Science and Technology Agency (JST) (December 2001 - November 2004)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2005 - March 2006)
    Funded by Grant-in-Aid for Scientific Research (B)/Japan Society for the Promotion of Science (JSPS) (April 2005 - March 2008)
    Funded by BIRD/Japan Science and Technology Agency (JST) (September 2005 - September 2008)
    Funded by BIRD/Japan Science and Technology Agency (JST) (October 2007 - September 2010)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2011 - March 2012)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2012 - March 2013)
    Supported by the commission for the Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI) (October 2012 - )